GlassScriptPhysician profile
Arun Kundra
NPI 1477717833
$6,746.99
in general payments reported to CMS, 2019-2025
21 companies · $845 in 2025
The $845 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,052 · 2020: $113 · 2021: $45.93 · 2022: $1,802 · 2023: $904 · 2024: $984 · 2025: $845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,732.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,731.78 | 2019 | |
| Abbott Laboratories | $1,157.19 | 2022 | |
| Pfizer INC. | $915.54 | 2019-2025 | |
| Medtronic, INC. | $794.28 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Affera Mapping System, Na |
| E.R. Squibb & Sons, L.L.C. | $634.50 | 2022-2025 | Camzyos, Eliquis |
| Impulse Dynamics (USA) INC. | $476.92 | 2022-2025 | Optimizer, Optimizer |
| Janssen Pharmaceuticals, INC | $173.56 | 2022-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $169.67 | 2022-2025 | Farxiga, Brilinta, Lokelma |
| Atricure, INC. | $149.00 | 2019-2022 | |
| Biosense Webster, INC. | $138.17 | 2019 | |
| Scpharmaceuticals INC. | $116.65 | 2024-2025 | |
| Zoll Respicardia, INC. | $106.80 | 2022 | |
| Philips North America LLC | $80.05 | 2020 | |
| Boston Scientific Corporation | $33.24 | 2019-2024 | Watchman Access System |
| Amgen INC. | $17.22 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.39 | 2020 | |
| Sanofi-Aventis U.S. LLC | $13.80 | 2019 | |
| Lundbeck LLC | $11.97 | 2019 | |
| Pacira Therapeutics, INC. | $11.26 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Kundra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.